CIC
CRBU icon

Cornercap Investment Counsel’s Caribou Biosciences CRBU Stock Holding History

Cornercap Investment Counsel’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,522
Closed -$32.4K – 483
2024
Q3 		$32.4K Sell
16,522
-18,783
-53% -$38.5K 0.01% 512
2024
Q2 		$57.9K Sell
35,305
-449
-1% -$1.44K 0.01% 579
2024
Q1 		$184K Buy
+35,754
New +$220K 0.03% 573
2023
Q3 		– Sell
-39,230
Closed -$167K – 589
2023
Q2 		$167K Hold
39,230
– – 0.03% 528
2023
Q1 		$208K Buy
39,230
+1,605
+4% +$10K 0.04% 500
2022
Q4 		$236K Buy
+37,625
New +$335K 0.04% 499

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cornercap Investment Counsel's CRBU Position: Q4 2024 in Review

Cornercap Investment Counsel sold out of Caribou Biosciences (CRBU) in Q4 2024, closing a stake of 16,522 shares — an estimated $32.4K sold.

Cornercap Investment Counsel first reported a position in CRBU in Q4 2022 and held it in 6 quarters. The position peaked at $236K in Q4 2022. 133 funds tracked by Wall St. Rank hold CRBU as of Q4 2024.

  • Cornercap Investment Counsel reported no remaining Caribou Biosciences position as of Q4 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 16,522 Caribou Biosciences shares in Q4 2024, an estimated $32.4K.
  • Cornercap Investment Counsel first reported a position in Caribou Biosciences in Q4 2022 and held it in 6 quarters.
  • Cornercap Investment Counsel's Caribou Biosciences position peaked at $236K in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2024.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.